The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculation

Immunology

Volumn 136, Issue 3, 2012, Pages 325-333

  Chong, Deborah L W ^a   Ingram, Rebecca J ^a,b   Lowther, Daniel E ^a   Muir, Roshell ^b   Sriskandan, Shiranee ^a   Altmann, Daniel M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bacterial immunity; Infection; Interleukin 17A; Natural killer cells; Streptococcus pyogenes; T helper type 17 cells

Indexed keywords

INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GROUP A STREPTOCOCCAL INFECTION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, BACTERIAL; BASE SEQUENCE; DNA PRIMERS; FEMALE; HLA-DQ ANTIGENS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; MICE; MICE, TRANSGENIC; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TH17 CELLS; TIME FACTORS; UP-REGULATION;

EID: 84861755491     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2012.03584.x     Document Type: Article

References (57)

1. Rouvier E, Luciani MF, Mattéi MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150:5445-56.
2. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010; 159:109-19.
3. H17 cells. Nature 2008; 453:1051-7.
4. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10:479-89.
5. Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 2009; 126:177-85.
6. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009; 119:1899-909.
7. Ye P, Rodriguez FH, Kanaly S et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001; 194:519-27.
8. Ye P, Garvey PB, Zhang P et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001; 25:335-40.
9. O'Brien RL, Roark CL, Born WK. IL-17-producing γδ T cells. Eur J Immunol 2009; 39:662-6.
10. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL. γδ T cells: an important source of IL-17. Curr Opin Immunol 2008; 20:353-7.
11. Passos ST, Silver JS, O'Hara AC, Sehy D, Stumhofer JS, Hunter CA. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol 2010; 184:1776-83.
12. +γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J Immunol 2007; 178:4466-72.
13. Hamada S, Umemura M, Shiono T et al. IL-17A produced by γδ plays a critical role in innate immunity against Listeria monocytogenes infection in the liver. J Immunol 2008; 181:3456-63.
14. Siegemund S, Schütze N, Schulz S, Wolk K, Nasilowska K, Straubinger RK, Sabat R, Alber G. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis. Int Immunol 2009; 21:555-65.
15. Flierl MA, Rittirsch D, Gao H et al. Adverse functions of IL-17A in experimental sepsis. FASEB J 2008; 22:2198-205.
16. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
17. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6:813-22.
18. Russell JA. Management of sepsis. N Engl J Med 2006; 355:1699-713.
19. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol 2008; 214:211-23.
20. Reinhart K, Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 2001; 29:S121-5.
21. Sriskandan S, Faulkner L, Hopkins P. Streptococcus pyogenes: insight into the function of the streptococcal superantigens. Intl J Biochem Cell Biol 2006; 39:12-9.
22. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol 2003; 133:299-306.
23. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002; 2:156-62.
24. Pählman LI, Olin AI, Darenberg J, Mörgelin M, Kotb M, Herwald H, Norrby-Teglund A. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 2008; 10:404-14.
25. Robinson JH, Case MC, Kehoe MA. Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins. Infect Immun 1993; 61:1062-8.
26. Li H, Nooh MM, Kobt M, Re F. Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production. J Leukoc Biol 2008; 83:409-18.
27. Arvand M, Schneider T, Jahn HU, Hahn H. Streptococcal toxic shock syndrome associated with marked γδ T cell expansion: case report. Clin Infect Dis 1996; 22:362-5.
28. Wang B, Dileepan T, Briscoe S, Hyland KA, Kang J, Khoruts A, Cleary PP. Induction of TGF-β1 and TGF-β1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci USA 2010; 107:5937-42.
29. Faulkner L, Altmann DM, Ellmerich S, Huhtaniemi I, Stamp G, Sriskandan S. Sexual dimorphism in superantigen shock involves elevated TNF-α and TNF-α induced hepatic apoptosis. Am J Respir Crit Care Med 2007; 176:473-82.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 2001; 29:e45.
31. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res 2002; 30:e36.
32. + T cells during primary and secondary viral infections. J Immunol 2005; 174:5936-40.
33. + T helper cells. Cell 2006; 126:1121-33.
34. H-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat Immunol 2008; 9:641-9.
35. + regulatory T cells. Proc Natl Acad Sci USA 2008; 105:18460-5.
36. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang S. IL-17 cytokine family. J Allergy Clin Immunol 2004; 114:1265-73.
37. Gaffen S. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009; 9:556-67.
38. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010; 129:311-21.
39. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011; 34:149-62.
40. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
41. Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 2011; 134:8-16.
42. Islander U, Andersson A, Lindberg E, Adlerberth I, Wold AE, Rudin A. Superantigenic Staphylococcus aureus stimulates production of interleukin-17 from memory but not naive T cells. Infect Immun 2010; 78:381-6.
43. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, Strasser A, Hotchkiss RS. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J 2007; 21:708-19.
44. Mathers AR, Janelsins BM, Rubin JP, Tkacheva OA, Shufesky WJ, Watkins SC, Morelli AE, Larregina AT. Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J Immunol 2009; 182:921-33.
45. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma injury. Injury 2007; 38:1336-45.
46. Schneider DF, Palmer JL, Tulley JM, Speicher JT, Kovacs EJ, Gamelli RL, Faunce DE. A novel role for NKT cells in cutaneous wound repair. J Surg Res 2011; 168:325-33.
47. Kobayashi K, Tsuda Y, Yoshida T, Takeuchi D, Utsunomiya T, Takahashi H, Suzuki F. Bacterial sepsis and chemokines. Curr Drug Targets 2006; 7:119-34.
48. Frangen TM, Bogdanski D, Schinkel C, Roetman B, Kälicke T, Muhr G, Köller M. Systemic IL-17 after severe injuries. Shock 2008; 29:462-7.
49. Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, Rocha AM, Jeschke MG. Cytokine expression profile over time in severely burned pediatric patients. Shock 2006; 26:13-9.
50. Finnerty CC, Przkora R, Herndon DN, Jeschke MG. Cytokine expression profile over time in burned mice. Cytokine 2009; 45:20-5.
51. Hayday AC. γδ T cells and the lymphoid stress-surveillance response. Immunity 2009; 31:184-96.
52. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 1998; 279:1737-40.
53. Schneider DF, Glenn CH, Faunce DE. Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis. J Burn Care Res 2007; 28:365-79.
54. Barkhausen T, Frerker C, Putz C, Pape H, Krettek C, van Griensven M. Depletion of NK cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response. Shock 2008; 30:401-10.
55. Goldmann O, Chhatwal GS, Medina E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J Infect Dis 2005; 191:1280-6.
56. Godshall CJ, Scott MJ, Burch PT, Peyton JC, Cheadle WG. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 2003; 19:144-9.
57. + T cells by bacterial superantigen-primed Kupffer cells. Hepatology 1999; 30:430-6.